Surgery Partners (NASDAQ:SGRY) Price Target Cut to $19.00 by Analysts at Mizuho

Surgery Partners (NASDAQ:SGRY) had its price target dropped by investment analysts at Mizuho from $22.00 to $19.00 in a research report issued on Thursday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s price target would suggest a potential upside of 20.25% from the stock’s current price.

A number of other equities research analysts also recently weighed in on SGRY. UBS Group dropped their price target on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, November 13th. JPMorgan Chase & Co. cut their price target on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research note on Monday, November 24th. Barclays reduced their price target on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Friday, November 21st. Weiss Ratings restated a “sell (d-)” rating on shares of Surgery Partners in a report on Monday, December 8th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $36.00 price target on shares of Surgery Partners in a research note on Tuesday, October 7th. Seven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Surgery Partners has an average rating of “Moderate Buy” and an average price target of $27.11.

Surgery Partners Stock Up 1.8%

NASDAQ SGRY opened at $15.80 on Thursday. The stock has a market capitalization of $2.04 billion, a P/E ratio of -11.62 and a beta of 1.93. Surgery Partners has a 52 week low of $14.94 and a 52 week high of $26.16. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. The stock has a fifty day moving average of $18.55 and a 200-day moving average of $20.89.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $821.50 million during the quarter, compared to the consensus estimate of $823.55 million. Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. Surgery Partners’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.19 EPS. On average, equities research analysts forecast that Surgery Partners will post 0.67 EPS for the current year.

Hedge Funds Weigh In On Surgery Partners

Institutional investors and hedge funds have recently modified their holdings of the business. AlphaQuest LLC lifted its stake in Surgery Partners by 112.0% in the first quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after buying an additional 559 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Surgery Partners by 313.1% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock worth $27,000 after purchasing an additional 930 shares during the period. PNC Financial Services Group Inc. increased its holdings in Surgery Partners by 86.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock worth $28,000 after purchasing an additional 542 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of Surgery Partners by 45,640.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after purchasing an additional 2,282 shares during the period. Finally, FNY Investment Advisers LLC bought a new stake in shares of Surgery Partners in the second quarter valued at about $115,000.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.